Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$1.01 - $1.44 $120,766 - $172,182
119,571 Added 25.97%
579,980 $806,000
Q1 2023

May 03, 2023

BUY
$1.18 - $2.59 $543,282 - $1.19 Million
460,409 New
460,409 $543,000

Others Institutions Holding ORGS

About Orgenesis Inc.


  • Ticker ORGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,545,800
  • Market Cap $28.1M
  • Description
  • Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...
More about ORGS
Track This Portfolio

Track Redmond Asset Management, LLC Portfolio

Follow Redmond Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmond Asset Management, LLC with notifications on news.